Key Record Dates Identifier: NCT01650701
Brief Title: A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma (RELEVANCE)

First Submitted : July 24, 2012
First Submitted that Met QC Criteria : July 24, 2012
First Posted : July 26, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : April 18, 2019
Last Update Posted : April 22, 2019